Friday, 20 November 2026NewsWorldBusinessTech
Latest

Washington University Researchers Find Blood Test Tracks CTE in Study

Researchers have identified a blood protein fragment that tracked advanced chronic traumatic encephalopathy in a small group of former football players, according to a study published Nov. 19 in JAMA.

Detecting Tau Pathology During Life

Scientists investigating the connection between football and brain damage have long described diagnosing chronic traumatic encephalopathy in living patients as the primary goal. Researchers at Boston University and Banner Health used an assay to evaluate whether a blood test could identify the degenerative brain disease in living people.

The study included 21 former American football players who provided blood samples during their lives and subsequently donated their brains for research through Boston University CTE Center Studies. Autopsies confirmed that 18 of the participants had CTE, including 16 with high-stage disease. Twelve players had played professionally, seven in college, and two only in high school.

spot abnormal tau

“This is a study of hope and optimism,” said Michael Alosco, a co-senior author of the paper and co-director of clinical research at the BU CTE Center.

“It’s a study that really brings us closer to being able to diagnose during life,” Alosco told The Boston Globe. He said this is what researchers have worked on for years.

eMTBR-Tau Levels Distinguish CTE Stages

The analysis examined plasma levels of endogenously cleaved microtubule-binding region tau, known as eMTBR-tau. Researchers found that eMTBR-tau concentrations were much higher in high-stage CTE than in low-stage CTE or in participants without the disease. Median eMTBR-tau levels were 0.019 picograms per milliliter in players with CTE, compared with 0.001 in those without it.

Washington University Researchers Find Blood Test Tracks CTE in Study
Photo: WashU Medicine

Five of the CTE cases also involved Alzheimer’s disease, with eMTBR-tau levels reaching their highest points in people who experienced both conditions. Investigators measured p-tau217, an established blood marker for Alzheimer’s disease. It was elevated exclusively in people with Alzheimer’s pathology and showed no association with CTE.

“This is a game changer,” Alosco told ESPN.

Boston researchers say new blood test could help detect CTE in living patients — Boston 25 News

“If future studies validate these findings, this blood test will allow us to detect CTE with a high level of accuracy,” Alosco said.

WashU Study Confirms Same Biomarker

A separate research group at the Washington University School of Medicine in St. Louis published a study in the same journal examining 11 cases and identifying the same biomarker. WashU Medicine researchers previously demonstrated that blood levels of the tau fragment reflect tau clumps in the brains of Alzheimer’s patients.

Washington University Researchers Find Blood Test Tracks CTE in Study
Photo: STAT

“Our study shows that an Alzheimer’s disease biomarker can be applied to other tauopathies, including CTE,” said Chihiro Sato, an assistant professor of neurology at WashU Medicine.

Boston University, a private research university founded in 1839 and chartered in Boston in 1869, is a member of the Association of American Universities. It enrolls nearly 38,000 students, employs more than 4,000 faculty, and is classified among R1 institutions for very high research activity.

Its medical campus in the South End houses the BU CTE Center, which has become a leading center for the study of chronic traumatic encephalopathy through its brain donation program and clinical research.

The findings offer a potential pathway for future clinical trials. Researchers said the work remains in the discovery phase and the test is not available for clinical use.